山东百龙创园生物科技股份有限公司2025年第四次临时股东会决议公告

Core Points - The company held its fourth extraordinary general meeting of shareholders on December 1, 2025, with no resolutions being rejected [2][3] - The meeting was convened by the board of directors and chaired by Chairman Dou Baode, utilizing a combination of on-site and online voting methods [2][3] - A special resolution regarding the company's previous fundraising usage report was approved, requiring more than two-thirds of the voting rights held by attending shareholders [3][5] Meeting Details - The meeting took place at the company's office building in Yucheng, Dezhou, Shandong Province [2] - All seven current directors attended the meeting, along with the board secretary and other senior executives [4] - The meeting's legal compliance was confirmed by Beijing Hairun Tianrui Law Firm, ensuring that all procedures and voting were in accordance with the Company Law and relevant regulations [5][6]